6B3N

Solution structure of the N-terminal domain of the effector NleG5-1 from Escherichia coli O157:H7 str. Sakai

SOLUTION NMR

---

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	400 uM [U-100% 13C; U-100% 15N] NleG5-1, 15 mM HEPES, 250 mM sodium chloride, 5 mM L-arginine, 5 mM sodium citrate, 1 mM benzamidine, 10 uM DTT, 0.01 % w/v sodium azide	90% H2O/10% D2O	400 mM	7.5	1 atm	303	Bruker AVANCE 500
2	2D 1H-13C HSQC	400 uM [U-100% 13C; U-100% 15N] NleG5-1, 15 mM HEPES, 250 mM sodium chloride, 5 mM L-arginine, 5 mM sodium citrate, 1 mM benzamidine, 10 uM DTT, 0.01 % w/v sodium azide	90% H2O/10% D2O	400 mM	7.5	1 atm	303	Bruker AVANCE 500
3	3D HNCA	400 uM [U-100% 13C; U-100% 15N] NleG5-1, 15 mM HEPES, 250 mM sodium chloride, 5 mM L-arginine, 5 mM sodium citrate, 1 mM benzamidine, 10 uM DTT, 0.01 % w/v sodium azide	90% H2O/10% D2O	400 mM	7.5	1 atm	303	Bruker AVANCE 500
4	3D HNCO	400 uM [U-100% 13C; U-100% 15N] NleG5-1, 15 mM HEPES, 250 mM sodium chloride, 5 mM L-arginine, 5 mM sodium citrate, 1 mM benzamidine, 10 uM DTT, 0.01 % w/v sodium azide	90% H2O/10% D2O	400 mM	7.5	1 atm	303	Bruker AVANCE 500
5	3D CBCA(CO)NH	400 uM [U-100% 13C; U-100% 15N] NleG5-1, 15 mM HEPES, 250 mM sodium chloride, 5 mM L-arginine, 5 mM sodium citrate, 1 mM benzamidine, 10 uM DTT, 0.01 % w/v sodium azide	90% H2O/10% D2O	400 mM	7.5	1 atm	303	Bruker AVANCE 500
9	3D HBHA(CO)NH	400 uM [U-100% 13C; U-100% 15N] NleG5-1, 15 mM HEPES, 250 mM sodium chloride, 5 mM L-arginine, 5 mM sodium citrate, 1 mM benzamidine, 10 uM DTT, 0.01 % w/v sodium azide	90% H2O/10% D2O	400 mM	7.5	1 atm	303	Bruker AVANCE 500
8	3D 1H-13C NOESY aliphatic	400 uM [U-100% 13C; U-100% 15N] NleG5-1, 15 mM HEPES, 250 mM sodium chloride, 5 mM L-arginine, 5 mM sodium citrate, 1 mM benzamidine, 10 uM DTT, 0.01 % w/v sodium azide	90% H2O/10% D2O	400 mM	7.5	1 atm	303	Bruker AVANCE II 800
7	3D 1H-13C NOESY aromatic	400 uM [U-100% 13C; U-100% 15N] NleG5-1, 15 mM HEPES, 250 mM sodium chloride, 5 mM L-arginine, 5 mM sodium citrate, 1 mM benzamidine, 10 uM DTT, 0.01 % w/v sodium azide	90% H2O/10% D2O	400 mM	7.5	1 atm	303	Bruker AVANCE II 800
6	3D 1H-15N NOESY	400 uM [U-100% 13C; U-100% 15N] NleG5-1, 15 mM HEPES, 250 mM sodium chloride, 5 mM L-arginine, 5 mM sodium citrate, 1 mM benzamidine, 10 uM DTT, 0.01 % w/v sodium azide	90% H2O/10% D2O	400 mM	7.5	1 atm	303	Bruker AVANCE II 800
12	3D 1H-13C NOESY aromatic	400 uM [U-100% 13C; U-100% 15N] NleG5-1, 15 mM HEPES, 250 mM sodium chloride, 5 mM L-arginine, 5 mM sodium citrate, 1 mM benzamidine, 10 uM DTT, 0.01 % w/v sodium azide	90% H2O/10% D2O	400 mM	7.5	1 atm	303	Bruker AVANCE II 800
10	3D HCCH-TOCSY	400 uM [U-100% 13C; U-100% 15N] NleG5-1, 15 mM HEPES, 250 mM sodium chloride, 5 mM L-arginine, 5 mM sodium citrate, 1 mM benzamidine, 10 uM DTT, 0.01 % w/v sodium azide	90% H2O/10% D2O	400 mM	7.5	1 atm	303	Bruker AVANCE II 800
11	3D CCH-TOCSY	400 uM [U-100% 13C; U-100% 15N] NleG5-1, 15 mM HEPES, 250 mM sodium chloride, 5 mM L-arginine, 5 mM sodium citrate, 1 mM benzamidine, 10 uM DTT, 0.01 % w/v sodium azide	90% H2O/10% D2O	400 mM	7.5	1 atm	303	Bruker AVANCE II 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE II	800
2	Bruker	AVANCE	500

NMR Refinement
Method	Details	Software
molecular dynamics	water refinement	CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin		Bruker Biospin
5	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
6	peak picking	Sparky		Goddard
2	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
3	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
7	chemical shift assignment	ABACUS		Lemak and Arrowsmith